ORIX Corporation
IX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | -0.12 | -0.25 | -0.28 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 40.61 | 56.92 | 27.43 | 21.78 |
| Quality | ||||
| ROIC | 1.13% | 0.77% | 0.24% | 0.47% |
| Gross Margin | 88.62% | 92.14% | 41.12% | 39.66% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 10.11% | 9.70% | 11.54% | 9.74% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 22.23 | 33.28 | 24.05 | 19.06 |
| Interest Coverage | 4.87 | 3.43 | 0.92 | 2.31 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -53.63 | -230.29 | 225.04 | 131.90 |